Zymeworks to open new EU HQ in Dublin, Ireland
June 22, 2023Business Services Dublin, Oncology, Zymeworks, headquarters, regulatory affiars
Canadian biotech company Zymeworks has announced plans to open its new Clinical and Regulatory EU headquarters in Dublin, Ireland. Zymework …
Eli Lilly to acquire DICE Therapeutics for immunology innovations
June 21, 2023Business Services DICE Therapeutics, Eli Lilly, Immunology, acquisition, immunology
Eli Lilly and DICE Therapeutics have announced a definitive agreement for Lilly to acquire DICE, a biopharmaceutical company focusing on …
GSK shares positive data for RSV vaccine
June 21, 2023Research and Development GSK, Immunology, RSV, Vaccine, clinical trial
GSK have announced new positive data from the AReSVi-006 phase 3 trial which assessed the efficacy of a single dose …
FDA approves Pfizer’s HRR mCRPC drug
June 21, 2023Medical Communications FDA, Oncology, Pfizer, breast cancer, oncology, prostate cancer
US-based pharmaceutical and biotechnology company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its homologous …
PharmaTher and Vitruvias sign collaboration agreement to commercialise ketamine-based treatment in the US
June 21, 2023Medical Communications Ketamine, Neurology, PharmaTher, Vitruvias, commercialisation
Specialty pharmaceutical companies, Canadian PharmaTher and US-based Vitruvias, have entered into a commercialisation partnership to bring Ketarx products to the …
Sirnaomics advances isSCC candidate into late-stage clinical development
June 20, 2023Research and Development FDA, Oncology, Sirnaomics, clinical trial, isSCC
Global RNA therapeutics biopharmaceutical company Sirnaomics has announced that it has advanced its Squamous Cell Carcinoma in situ (isSCC) candidate …
Abu Dhabi’s Department of Health, M42 and AbbVie enter strategic partnership
June 20, 2023Medical Communications AbbVie, Abu Dhabi, DoH, M42, Oncology, strategic partnership
Abu Dhabi’s Department of Health (DoH) has signed a Memorandum of Understanding (MoU) with AbbVie and M42 to advance research …
GSK announces extension of FDA’s review for momelotinib
June 20, 2023Medical Communications FDA, GSK, Oncology, momelotinib, new drug application
GSK has announced that the US Food and Drug Administration (FDA) has extended its review period for the new drug …
Santhera and Catalyst Pharmaceuticals sign $231m license and collaboration deal
June 20, 2023Medical Communications Catalyst Pharmaceuticals, Rare Diseases, Vamorolone, licence and collaboration, santhera
Swiss specialty pharmaceutical company Santhera and US-based biopharmaceutical company Catalyst Pharmaceuticals have announced that they have signed an exclusive license …
Immodulon appoints Josefine Roemmler-Zehrer as chief medical officer
June 20, 2023Immodulon, Josefine Roemmler-Zehrer, appointment, chief medical officer
Cancer immunotherapy company Immodulon has announced that it has appointed Josefine Roemmler-Zehrer as chief medical officer, bringing with her vast …
Scientists develop 3D printed pills for time-controlled release
June 19, 2023Research and Development 3d printed pills, 3d printing, Max Planck Insititute, Pharmacy, University of California
A team of scientists at the Max Planck Institute (MPI) for Informatics, Germany, and the University of California, US, have …
Vaxxas opens manufacturing facility for needle-free vaccine patch
June 19, 2023Research and Development Immunology, Vaxxas, manufacturing, needle-free vaccines, vaccines
Clinical stage biotech company Vaxxas has announced that it is opening a biomedical manufacturing facility in Brisbane, Australia, for the …
ImmuPharma initiates phase 2/3 clinical trial for lupus treatment
June 19, 2023Research and Development Avion Pharmaceuticals, ImmuPharma, Immunology, Lupus, clinical trial
ImmuPharma has announced that it will commence a phase 2/3 adaptive clinical trial of P140 (Lupuzor) in patients with systemic …
Rani Therapeutics’ oral ‘robotic pill’ delivers injection trans-enterically
June 19, 2023Medical Communications Osteoporosis, Rani Therapeutics, injection, osteoporosis, robotic pill, robotics
US Rani Therapeutics, a clinical-stage biotherapeutics company, has reported new results from its phase 1 trial into the RaniPill capsule …
LEO Pharma appoints Leanne Walsh as general manager and vice president for UK and Ireland
June 19, 2023LEO Pharma, appointment, general manager, vice president
Medical dermatology company LEO Pharma has announced that it has appointed Leanne Walsh as its new general manager and vice …
Nordic Bioscience receives FDA Letter of Support for biomarker in aggressive tumour fibrosis
June 16, 2023Research and Development FDA, Nordic Bioscience, Oncology, Roche, tumour fibrosis
Danish biomarker company Nordic Bioscience has announced that the US Food and Drug Administration (FDA) has awarded it a Letter …
Takeda and HUTCHMED’s cancer drug shown to prolong overall survival
June 16, 2023Research and Development HUTCHMED, Oncology, Takeda, colorectal cancer
Clinical trial data from a study into the metastatic colorectal cancer (CRC) drug fruquintinib, which is being developed by Japanese …
FDA gives Eagle Pharmaceuticals Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for SCABP drug
June 15, 2023Research and Development Eagle Pharmaceuticals, FDA, FDA fast-track, Immunology, SCABP
US-based pharmaceutical company Eagle Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted its severe community-acquired …
Astellas and Cullgen enter into $1.9bn strategic collaboration to progress protein degraders
June 15, 2023Research and Development Astellas, Cullgen, Oncology, protein degraders
Japanese pharmaceutical company Astellas and US-based clinical-stage biopharmaceutical company Cullgen have announced that they have entered into a strategic research …
Critical Path Institute receives FDA Biomarker LOS for DIPI biomarkers
June 14, 2023Research and Development Critical Path Institute, Endocrinology, FDA, biomarkers, pancreatic injury
US-based Critical Path Institute (C-Path) has announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and …
